{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:49:03Z","timestamp":1774003743891,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Access to prevention options, including HIV pre-exposure prophylaxis (PrEP), remains a public health priority for gay, bisexual, and other men who have sex with men (MSM), especially in London. We describe PrEP use in a London community sample of MSM before the introduction of a national PrEP programme in October 2020.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From June\u2013August 2019, MSM aged\u2009\u2265\u200918 recruited from London commercial venues were asked to self-complete a sexual health questionnaire and provide an oral fluid sample for anonymous HIV antibody testing. Descriptive analyses of demographic characteristics, service engagement and outcomes, as well as sexual risk and prevention behaviours were examined in the survey population and in those reporting current PrEP use. We performed sequential, multivariate analyses examining current PrEP use in MSM of self-perceived HIV-negative\/unknown status with identified PrEP-need defined as the report of condomless anal sex (CAS) in the last three months, or the report of CAS (in the last year) with an HIV-positive\/unknown status partner not known to be on HIV treatment, in reflection of UK PrEP guidelines.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>One thousand five hundred and thirty-fifth questionnaires were completed across 34 venues, where 1408 were analysed. One in five MSM of self-perceived HIV-negative\/unknown status reported current PrEP use (19.7%, 242\/1230). In men with PrEP-need, 68.2% (431\/632) did not report current use. Current PrEP use was associated with age (aOR: 3.52, 95% CI: 1.76\u20137.02 in men aged 40\u201344 vs men aged 18\u201325) and education (aOR: 1.72, 95% CI: 1.01\u20132.92 in men with\u2009\u2265\u20092\u00a0years\/still full-time vs no\/\u2009&lt;\u20092\u00a0years of education since age 16).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Among MSM in London, PrEP use is high but there is indication of unmet PrEP-need in men of younger age and lower levels of post-16 education. National programme monitoring and evaluation will require continued community monitoring to guide interventions ensuring equitable PrEP access and uptake in those who could most benefit from PrEP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-022-13425-0","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T07:04:09Z","timestamp":1654239849000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["PrEP use and unmet PrEP-need among men who have sex with men in London prior to the implementation of a national PrEP programme, a cross-sectional study from June to August 2019"],"prefix":"10.1186","volume":"22","author":[{"given":"Dana","family":"Ogaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"Logan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyrone J.","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorraine","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Poorvi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Macri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Noel Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"13425_CR1","unstructured":"Public Health England. Trends in HIV testing, new diagnoses and people receiving HIV-related care in the UK: data to end December 2019 Health Protection Report Volume 14 Number 20 2020 [Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/931964\/hpr2020_hiv19.pdf."},{"key":"13425_CR2","unstructured":"Mitchell H AH, Sonubi T, Kuyumdzhieva G, Harb A, Shah A, Glancy M, Checchi M,, Milbourn H FK, Mohammed H and contributors. Sexually transmitted infections and screening for chlamydia in England, 2019. Public Health England, London; 2020."},{"key":"13425_CR3","unstructured":"Department for Health and Social Care. Towards Zero - An action plan towards ending HIV transmission, AIDS and HIV-related deaths in England - 2022 to 2025. 2021."},{"issue":"7","key":"13425_CR4","doi-asserted-by":"publisher","first-page":"e440","DOI":"10.1016\/S2352-3018(21)00044-8","volume":"8","author":"F Brizzi","year":"2021","unstructured":"Brizzi F, Birrell PJ, Kirwan P, Ogaz D, Brown AE, Delpech VC, et al. Tracking elimination of HIV transmission in men who have sex with men in England: a modelling study. Lancet HIV. 2021;8(7):e440\u20138.","journal-title":"Lancet HIV"},{"issue":"10013","key":"13425_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","volume":"387","author":"S McCormack","year":"2016","unstructured":"McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet (London, England). 2016;387(10013):53\u201360.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"13425_CR6","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1016\/S2352-3018(17)30089-9","volume":"4","author":"JM Molina","year":"2017","unstructured":"Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, et al. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Lancet HIV. 2017;4(9):e402\u201310.","journal-title":"Lancet HIV"},{"issue":"11","key":"13425_CR7","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/S2352-3018(18)30215-7","volume":"5","author":"AE Grulich","year":"2018","unstructured":"Grulich AE, Guy R, Amin J, Jin F, Selvey C, Holden J, et al. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Lancet HIV. 2018;5(11):e629\u201337.","journal-title":"Lancet HIV"},{"key":"13425_CR8","doi-asserted-by":"publisher","unstructured":"Hayes Rosalie, Schmidt Axel J, Pharris Anastasia, Azad Yusef, Brown Alison E, Weatherburn Peter, et al. Estimating the \u2018PrEP Gap\u2019: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019. Euro Surveill. 2019;24(41). https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.41.1900598.","DOI":"10.2807\/1560-7917.ES.2019.24.41.1900598"},{"issue":"7","key":"13425_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1136\/sextrans-2019-054009","volume":"95","author":"HD Mitchell","year":"2019","unstructured":"Mitchell HD, Desai S, Mohammed H, Ong KJ, Furegato M, Hall V, et al. Preparing for PrEP: estimating the size of the population eligible for HIV pre-exposure prophylaxis among men who have sex with men in England. Sexually Trans Infect. 2019;95(7):484\u20137.","journal-title":"Sexually Trans Infect"},{"key":"13425_CR10","unstructured":"I Want PrEP Now; Terrence Higgins Trust. I Want PrEP Now: Homepage 2021 [Available from: https:\/\/www.iwantprepnow.co.uk\/."},{"key":"13425_CR11","unstructured":"NHS England. PrEP Impact Trial Update \u2013 June 2019 2019 [Available from: https:\/\/www.england.nhs.uk\/commissioning\/spec-services\/npc-crg\/blood-and-infection-group-f\/f03\/prep-trial-updates\/#June."},{"issue":"Suppl 2","key":"13425_CR12","first-page":"s2","volume":"20","author":"M Brady","year":"2019","unstructured":"Brady M, Rodger A, Asboe D, Cambiano V, Clutterbuck D, Desai M, et al. BHIVA\/BASHH guidelines on the use of HIV pre-exposure prophylaxis (PrEP) 2018. HIV Med. 2019;20(Suppl 2):s2\u201380.","journal-title":"HIV Med"},{"key":"13425_CR13","unstructured":"European Centre for Disease Prevention and Control. HIV Pre-Exposure Prophylaxis in the EU\/EEA and the UK: implementation, standards and monitoring : Operational guidance Stockholm: European Centre for Disease Prevention and Control; 2021 [Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/HIV-Pre-Exposure-Prophylaxis-in-the-EU-EEA-UK.pdf."},{"key":"13425_CR14","doi-asserted-by":"publisher","unstructured":"Saunders John, Gill O Noel, Delpech Valerie, Estcourt Claudia, the Five Nations (England, Scotland, Wales, Northern Ireland, Republic of Ireland) PrEP Minimum Dataset Working Group. Minimum dataset for monitoring national human immunodeficiency virus pre-exposure prophylaxis (HIV PrEP) programmes: a five-nation consensus, 2019. Euro Surveill. 2021;26(23). https:\/\/doi.org\/10.2807\/1560-7917.ES.2021.26.23.2001595.","DOI":"10.2807\/1560-7917.ES.2021.26.23.2001595"},{"issue":"9","key":"13425_CR15","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1016\/S2352-3018(16)30037-6","volume":"3","author":"A Aghaizu","year":"2016","unstructured":"Aghaizu A, Wayal S, Nardone A, Parsons V, Copas A, Mercey D, et al. Sexual behaviours, HIV testing, and the proportion of men at risk of transmitting and acquiring HIV in London, UK, 2000\u201313: a serial cross-sectional study. Lancet HIV. 2016;3(9):e431\u201340.","journal-title":"Lancet HIV"},{"key":"13425_CR16","doi-asserted-by":"publisher","unstructured":"Logan Louise, Fakoya Ibidun, Howarth Alison, Murphy Gary, Johnson Anne M, Rodger Alison J, et al. Combination prevention and HIV: a cross-sectional community survey of gay and bisexual men in London, October to December 2016. Euro Surveill. 2019;24(25). https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.25.1800312.","DOI":"10.2807\/1560-7917.ES.2019.24.25.1800312"},{"issue":"6","key":"13425_CR17","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/QAD.0000000000001006","volume":"30","author":"S Clifton","year":"2016","unstructured":"Clifton S, Nardone A, Field N, Mercer CH, Tanton C, Macdowall W, et al. HIV testing, risk perception, and behaviour in the British population. AIDS (London, England). 2016;30(6):943\u201352.","journal-title":"AIDS (London, England)"},{"issue":"10","key":"13425_CR18","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1177\/1359105319883927","volume":"26","author":"M Di Ciaccio","year":"2021","unstructured":"Di Ciaccio M, Sagaon-Teyssier L, Proti\u00e8re C, Mimi M, Suzan-Monti M, Meyer L, et al. Impact of HIV risk perception on both pre-exposure prophylaxis and condom use. J Health Psychol. 2021;26(10):1575\u201386.","journal-title":"J Health Psychol"},{"issue":"4","key":"13425_CR19","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/sextrans-2018-053773","volume":"95","author":"TC Witzel","year":"2019","unstructured":"Witzel TC, Nutland W, Bourne A. What are the motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men aged 18\u201345 in London? Results from a qualitative study. Sexually Trans Infect. 2019;95(4):262\u20136.","journal-title":"Sexually Trans Infect"},{"issue":"9","key":"13425_CR20","doi-asserted-by":"publisher","first-page":"e501","DOI":"10.1016\/S2468-2667(20)30186-9","volume":"5","author":"N Hanum","year":"2020","unstructured":"Hanum N, Cambiano V, Sewell J, Phillips AN, Rodger AJ, Speakman A, et al. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study. Lancet Public health. 2020;5(9):e501\u201311.","journal-title":"Lancet Public health"},{"key":"13425_CR21","doi-asserted-by":"publisher","unstructured":"O\u2019Halloran Charlotte, Owen Greg, Croxford Sara, Sims Lee B, Gill O Noel, Nutland Will, et al. Current experiences of accessing and using HIV pre-exposure prophylaxis (PrEP) in the United Kingdom: a cross-sectional online survey, May to July 2019. Euro Surveill. 2019;24(48). https:\/\/doi.org\/10.2807\/1560-7917.ES.2019.24.48.1900693.","DOI":"10.2807\/1560-7917.ES.2019.24.48.1900693"},{"issue":"sup2","key":"13425_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1080\/09540121.2020.1739219","volume":"32","author":"M Annequin","year":"2020","unstructured":"Annequin M, Villes V, Delabre RM, Alain T, Morel S, Michels D, et al. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017). AIDS Care. 2020;32(sup2):47\u201356.","journal-title":"AIDS Care"},{"issue":"14","key":"13425_CR23","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1001\/jama.2019.2947","volume":"321","author":"MW Traeger","year":"2019","unstructured":"Traeger MW, Cornelisse VJ, Asselin J, Price B, Roth NJ, Willcox J, et al. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection. JAMA. 2019;321(14):1380\u201390.","journal-title":"JAMA"},{"issue":"7","key":"13425_CR24","doi-asserted-by":"publisher","first-page":"e447","DOI":"10.1016\/S2352-3018(19)30136-5","volume":"6","author":"E Hoornenborg","year":"2019","unstructured":"Hoornenborg E, Coyer L, Achterbergh RCA, Matser A, Schim van der Loeff MF, Boyd A, et al. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. Lancet HIV. 2019;6(7):e447\u201355.","journal-title":"Lancet HIV."},{"issue":"2","key":"13425_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10461-018-2252-9","volume":"23","author":"MA Monta\u00f1o","year":"2019","unstructured":"Monta\u00f1o MA, Dombrowski JC, Dasgupta S, Golden MR, Duerr A, Manhart LE, et al. Changes in Sexual Behavior and STI Diagnoses Among MSM Initiating PrEP in a Clinic Setting. AIDS Behav. 2019;23(2):548\u201355.","journal-title":"AIDS Behav"},{"issue":"12","key":"13425_CR26","doi-asserted-by":"publisher","first-page":"e2030806","DOI":"10.1001\/jamanetworkopen.2020.30806","volume":"3","author":"H McManus","year":"2020","unstructured":"McManus H, Grulich AE, Amin J, Selvey C, Vickers T, Bavinton B, et al. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men. JAMA Netw Open. 2020;3(12):e2030806.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"13425_CR27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/QAD.0000000000002790","volume":"35","author":"C Estcourt","year":"2021","unstructured":"Estcourt C, Yeung A, Nandwani R, Goldberg D, Cullen B, Steedman N, et al. Population-level effectiveness of a national HIV preexposure prophylaxis programme in MSM. AIDS (London, England). 2021;35(4):665\u201373.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"13425_CR28","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1016\/S2352-3018(19)30341-8","volume":"7","author":"G Antoni","year":"2020","unstructured":"Antoni G, Tremblay C, Delaugerre C, Charreau I, Cua E, Rojas Castro D, et al. On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial. Lancet HIV. 2020;7(2):e113\u201320.","journal-title":"Lancet HIV"},{"issue":"12","key":"13425_CR29","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1093\/cid\/cix228","volume":"64","author":"ME Curlin","year":"2017","unstructured":"Curlin ME, Gvetadze R, Leelawiwat W, Martin M, Rose C, Niska RW, et al. Analysis of false-negative human immunodeficiency virus rapid tests performed on oral fluid in 3 international clinical research studies. Clin Infect Dis. 2017;64(12):1663\u20139.","journal-title":"Clin Infect Dis"},{"issue":"12","key":"13425_CR30","doi-asserted-by":"publisher","first-page":"e25419-e","DOI":"10.1002\/jia2.25419","volume":"22","author":"T Elliott","year":"2019","unstructured":"Elliott T, Sanders EJ, Doherty M, Ndung\u2019u T, Cohen M, Patel P, et al. Challenges of HIV diagnosis and management in the context of pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), test and start and acute HIV infection: a scoping review. J Int AIDS Soc. 2019;22(12):e25419-e.","journal-title":"J Int AIDS Soc."},{"issue":"14","key":"13425_CR31","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1097\/QAD.0000000000001577","volume":"31","author":"D Donnell","year":"2017","unstructured":"Donnell D, Ramos E, Celum C, Baeten J, Dragavon J, Tappero J, et al. The effect of oral preexposure prophylaxis on the progression of HIV-1 seroconversion. AIDS (London, England). 2017;31(14):2007\u201316.","journal-title":"AIDS (London, England)"},{"issue":"2","key":"13425_CR32","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.1016\/S2352-3018(19)30404-7","volume":"7","author":"V Tittle","year":"2020","unstructured":"Tittle V, Boffito M, McOwan A, Whitlock G. Antiretroviral resistance and management after pre-exposure prophylaxis. The Lancet HIV. 2020;7(2):e84.","journal-title":"The Lancet HIV"},{"issue":"4","key":"13425_CR33","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/QAD.0000000000003143","volume":"36","author":"N Girometti","year":"2022","unstructured":"Girometti N, McCormack S, Tittle V, McOwan A, Whitlock G. Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes. AIDS (London, England). 2022;36(4):561\u20136.","journal-title":"AIDS (London, England)"},{"key":"13425_CR34","volume-title":"HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis. Geneva: World Health Organization; 2020."},{"key":"13425_CR35","doi-asserted-by":"crossref","unstructured":"O'Halloran C, Croxford S, Mohammed H, Gill ON, Hughes G, Fifer H, et al. Factors associated with reporting antibiotic use as STI prophylaxis among HIV PrEP users: findings from a cross-sectional online community survey, May-July 2019, UK. Sexually transmitted infections. 2020.","DOI":"10.1136\/sextrans-2020-054592"},{"key":"13425_CR36","unstructured":"British Association for Sexual Health and HIV PHE. Position Statement on Doxycycline as PostExposure Prophylaxis for Sexually Transmitted Infections 2017 [updated 1\/10\/2020. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/656803\/Doxy_PEP_statement_v5_PHE_BASHH.pdf."},{"key":"13425_CR37","doi-asserted-by":"publisher","unstructured":"Arnold-Forster D, Horne R, Nutland W, Wayal S, Rayment M, Rae C, Desai M, Clarke A, Sullivan A, McCormack S, Gafos M. Perceptions and Practicalities Influencing Pre-exposure Prophylaxis Adherence Among Men Who Have Sex with Men in England. AIDS Behav. 2022. https:\/\/doi.org\/10.1007\/s10461-022-03624-6. Epub ahead of print. PMID: 35182281.","DOI":"10.1007\/s10461-022-03624-6"},{"issue":"48","key":"13425_CR38","doi-asserted-by":"publisher","first-page":"20981","DOI":"10.2807\/1560-7917.ES2014.19.48.20981","volume":"19","author":"EJ Savage","year":"2014","unstructured":"Savage EJ, Mohammed H, Leong G, Duffell S, Hughes G. Improving surveillance of sexually transmitted infections using mandatory electronic clinical reporting: the genitourinary medicine clinic activity dataset, England, 2009 to 2013. Eurosurveillance. 2014;19(48):20981.","journal-title":"Eurosurveillance"},{"key":"13425_CR39","unstructured":"UK Health Security Agency. GUMCAD STI Surveillance System Clinical Guidelines 2021 [Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/1032957\/GUMCAD_clinical_guidelines_2021.pdf."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-022-13425-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-022-13425-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T07:04:53Z","timestamp":1654239893000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-022-13425-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["13425"],"URL":"https:\/\/doi.org\/10.1186\/s12889-022-13425-0","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"25 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for this study was provided by the London Harrow Research Ethics Committee (REC reference 00\/0158). All methods were performed in accordance with relevant guidelines and regulations. Verbal informed consent was obtained from all participants and approved by the London Harrow Research Ethics Committee (REC reference 00\/0158).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"FB has received funding for development and presentation of educational materials from Gilead Sciences, Ltd. TJC was supported by a grant from the Medical Research Council (MR\/N013867\/1). DB received a research grant from Gilead Sciences, Ltd. AMJ is President of the Academy of Medical Sciences. All other authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1105"}}